Anti-Estrogens May Slow Lung Cancer Progression

Article

Women with breast cancer who are treated with anti-estrogens have a lower lung cancer mortality rate than the general population, according to a study published online Jan. 24 in Cancer.

 

MONDAY, Jan. 24 (HealthDay News) -- Women with breast cancer who are treated with anti-estrogens have a lower lung cancer mortality rate than the general population, according to a study published online Jan. 24 in Cancer.

Christine Bouchardy, M.D., from the University of Geneva, and colleagues reviewed data from 6,655 women diagnosed with breast cancer between 1980 and 2003 who registered at the Geneva Cancer Registry. Of those diagnosed, 3,066 women were treated with anti-estrogens. The women were followed up until December 2007 to identify how many developed and died from lung cancer. Incidence and mortality rates were compared with those expected in the general population. The investigators found that 40 of the women developed lung cancer. Standardized incidence ratios for lung cancer were not significantly lower for breast cancer patients, regardless of whether they were receiving anti-estrogen therapy. However, lung cancer mortality was significantly lower for women taking anti-estrogens, compared to those without anti-estrogens (standardized mortality ratios, 0.13 versus 0.76). "Anti-estrogen treatment for breast cancer was associated with a reduced risk of death from lung cancer, providing new evidence on the role of estrogen in lung cancer progression," the authors write. 

Abstract


Full Text (subscription or payment may be required)

Recent Videos
How sex differences impact treatment efficacy for chronic pain | Image Credit: profiles.ucalgary.ca.
Tuan Trang, PhD, discusses biological differences in chronic pain between men and women | Image Credit: profiles.ucalgary.ca.
1 expert is featured in this series.
How the Flyte device revolutionizes SUI management | Image Credit: linkedin.com.
Dr. Wanda Filer discusses how to overcome barriers to SUI treatment | Image Credit: linkedin.com.
Revi System shows efficacy against urgency urinary incontinence | Image Credit: ics.org.
1 expert is featured in this series.
Researchers highlight risks of breastfeeding while taking Levetiracetam | Image Credit: uwaterloo.ca.
Ipek Ensari, PhD, highlights improved mental health in chronic pelvic pain from physical activity | Image Credit: scholars.mssm.edu
New pSNM system empowers patients in urge urinary incontinence treatment | Image Credit: trinityhealthmichigan.org.
Related Content
© 2025 MJH Life Sciences

All rights reserved.